Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 6—June 2006
Research

Human Parechovirus Infections in Canada

Yacine Abed*† and Guy Boivin*†Comments to Author 
Author affiliations: *Centre Hospitalier Universitaire de Québec, Quebec City, Quebec, Canada; †Laval University, Quebec City, Quebec, Canada

Main Article

Figure 1

Cytopathic effects (CPEs) observed 3 days after infection of HT-29 cells with an enterovirus or a human parechovirus (HPeV)-1 isolate after 1 passage on this cell line (A); CPE observed 1 day after infection of LLC-MK2 cells with a HPeV-3 isolate after 3 passages on this cell line (B).

Figure 1. Cytopathic effects (CPEs) observed 3 days after infection of HT-29 cells with an enterovirus or a human parechovirus (HPeV)-1 isolate after 1 passage on this cell line (A); CPE observed 1 day after infection of LLC-MK2 cells with a HPeV-3 isolate after 3 passages on this cell line (B).

Main Article

Page created: January 04, 2012
Page updated: January 04, 2012
Page reviewed: January 04, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external